These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 39378883)

  • 1. An RNA damage response network mediates the lethality of 5-FU in colorectal cancer.
    Chen JK; Merrick KA; Kong YW; Izrael-Tomasevic A; Eng G; Handly ED; Patterson JC; Cannell IG; Suarez-Lopez L; Hosios AM; Dinh A; Kirkpatrick DS; Yu K; Rose CM; Hernandez JM; Hwangbo H; Palmer AC; Vander Heiden MG; Yilmaz ÖH; Yaffe MB
    Cell Rep Med; 2024 Oct; 5(10):101778. PubMed ID: 39378883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types.
    Chen JK; Merrick KA; Kong YW; Izrael-Tomasevic A; Eng G; Handly ED; Patterson JC; Cannell IG; Suarez-Lopez L; Hosios AM; Dinh A; Kirkpatrick DS; Yu K; Rose CM; Hernandez JM; Hwangbo H; Palmer AC; Vander Heiden MG; Yilmaz ÖH; Yaffe MB
    bioRxiv; 2023 Apr; ():. PubMed ID: 37162991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
    Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
    Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.
    Therizols G; Bash-Imam Z; Panthu B; Machon C; Vincent A; Ripoll J; Nait-Slimane S; Chalabi-Dchar M; Gaucherot A; Garcia M; Laforêts F; Marcel V; Boubaker-Vitre J; Monet MA; Bouclier C; Vanbelle C; Souahlia G; Berthel E; Albaret MA; Mertani HC; Prudhomme M; Bertrand M; David A; Saurin JC; Bouvet P; Rivals E; Ohlmann T; Guitton J; Dalla Venezia N; Pannequin J; Catez F; Diaz JJ
    Nat Commun; 2022 Jan; 13(1):173. PubMed ID: 35013311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.
    Du C; Huang D; Peng Y; Yao Y; Zhao Y; Yang Y; Wang H; Cao L; Zhu WG; Gu J
    Cancer Lett; 2017 Aug; 400():183-193. PubMed ID: 28465257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells.
    Frerker B; Bock F; Cappel ML; Kriesen S; Klautke G; Hildebrandt G; Manda K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer.
    Wang K; Liu W; Xu Q; Gu C; Hu D
    Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
    Smabers LP; Wensink E; Verissimo CS; Koedoot E; Pitsa KC; Huismans MA; Higuera Barón C; Doorn M; Valkenburg-van Iersel LB; Cirkel GA; Brousali A; Overmeer R; Koopman M; Braat MN; Penning de Vries B; Elias SG; Vries RG; Kranenburg O; Boj SF; Roodhart JM
    J Exp Clin Cancer Res; 2024 Feb; 43(1):61. PubMed ID: 38414064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells.
    Naghibalhossaini F; Shefaghat M; Mansouri A; Jaberi H; Tatar M; Eftekhar E
    Acta Med Iran; 2017 Dec; 55(12):751-758. PubMed ID: 29373881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-375-3p enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
    Xu F; Ye ML; Zhang YP; Li WJ; Li MT; Wang HZ; Qiu X; Xu Y; Yin JW; Hu Q; Wei WH; Chang Y; Liu L; Zhao Q
    Cancer Sci; 2020 May; 111(5):1528-1541. PubMed ID: 32073706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
    Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
    Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
    Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
    Christenson ES; Gizzi A; Cui J; Egleston M; Seamon KJ; DePasquale M; Orris B; Park BH; Stivers JT
    Mol Pharmacol; 2021 Jun; 99(6):412-425. PubMed ID: 33795350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of p62 in cell death and survival of 5-fluorouracil and oxaliplatin-resistant colorectal cancer cells.
    Zitkute V; Jasinevicius A; Vaitiekaite G; Kukcinaviciute E; Aleksandraviciute B; Eidenaite E; Sudeikis L; Jonusiene V; Sasnauskiene A
    J Cell Biochem; 2023 Nov; 124(11):1779-1791. PubMed ID: 37842885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
    Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
    PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
    Sakatani A; Sonohara F; Goel A
    Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Smorenburg CH; Peters GJ; van Groeningen CJ; Noordhuis P; Smid K; van Riel AM; Dercksen W; Pinedo HM; Giaccone G
    Ann Oncol; 2006 Jan; 17(1):35-42. PubMed ID: 16251201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.